DexCom (DXCM) revenue was $4.7B in FY2025 (+16% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$4.7B
+16%
2024
$4.0B
+11%
2023
$3.6B
+24%
2022
$2.9B
+19%
2021
$2.4B
+27%
2020
$1.9B
+31%
2019
$1.5B
+43%
2018
$1.0B
+44%
2017
$718M
+25%
2016
$573M
+43%
2015
$402M
+55%
2014
$259M
+62%
2013
$160M
+60%
2012
$100M
+31%
2011
$76M
+57%
2010
$49M
+64%
2009
$30M
Recent Quarterly Revenue
Quarter
Revenue
Q1 2026
$1.2B
Q4 2025
$1.3B
Q3 2025
$1.2B
Q2 2025
$1.2B
Q1 2025
$1.0B
Q4 2024
$1.1B
Q3 2024
$994M
Q2 2024
$1.0B
Q1 2024
$921M
Q4 2023
$1.0B
Q3 2023
$975M
Q2 2023
$871M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.